BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35487323)

  • 1. Planned delivery or expectant management in preeclampsia: an individual participant data meta-analysis.
    Beardmore-Gray A; Seed PT; Fleminger J; Zwertbroek E; Bernardes T; Mol BW; Battersby C; Koopmans C; Broekhuijsen K; Boers K; Owens MY; Thornton J; Green M; Shennan AH; Groen H; Chappell LC
    Am J Obstet Gynecol; 2022 Aug; 227(2):218-230.e8. PubMed ID: 35487323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial.
    Chappell LC; Brocklehurst P; Green ME; Hunter R; Hardy P; Juszczak E; Linsell L; Chiocchia V; Greenland M; Placzek A; Townend J; Marlow N; Sandall J; Shennan A;
    Lancet; 2019 Sep; 394(10204):1181-1190. PubMed ID: 31472930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Planned early delivery versus expectant management of the term suspected compromised baby for improving outcomes.
    Bond DM; Gordon A; Hyett J; de Vries B; Carberry AE; Morris J
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009433. PubMed ID: 26599471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Planned delivery or expectant management for late preterm pre-eclampsia in low-income and middle-income countries (CRADLE-4): a multicentre, open-label, randomised controlled trial.
    Beardmore-Gray A; Vousden N; Seed PT; Vwalika B; Chinkoyo S; Sichone V; Kawimbe AB; Charantimath U; Katageri G; Bellad MB; Lokare L; Donimath K; Bidri S; Goudar S; Sandall J; Chappell LC; Shennan AH;
    Lancet; 2023 Jul; 402(10399):386-396. PubMed ID: 37393919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Planned delivery for pre-eclampsia between 34 and 37 weeks of gestation: the PHOENIX RCT.
    Chappell LC; Brocklehurst P; Green M; Hardy P; Hunter R; Beardmore-Gray A; Bowler U; Brockbank A; Chiocchia V; Cox A; Duhig K; Fleminger J; Gill C; Greenland M; Hendy E; Kennedy A; Leeson P; Linsell L; McCarthy FP; O'Driscoll J; Placzek A; Poston L; Robson S; Rushby P; Sandall J; Scholtz L; Seed PT; Sparkes J; Stanbury K; Tohill S; Thilaganathan B; Townend J; Juszczak E; Marlow N; Shennan A
    Health Technol Assess; 2022 Nov; ():. PubMed ID: 36547875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome.
    Bond DM; Middleton P; Levett KM; van der Ham DP; Crowther CA; Buchanan SL; Morris J
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004735. PubMed ID: 28257562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of fetal growth restriction on latency in the setting of expectant management of preeclampsia.
    McKinney D; Boyd H; Langager A; Oswald M; Pfister A; Warshak CR
    Am J Obstet Gynecol; 2016 Mar; 214(3):395.e1-7. PubMed ID: 26767794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta-analysis.
    Bernardes TP; Zwertbroek EF; Broekhuijsen K; Koopmans C; Boers K; Owens M; Thornton J; van Pampus MG; Scherjon SA; Wallace K; Langenveld J; van den Berg PP; Franssen MTM; Mol BWJ; Groen H
    Ultrasound Obstet Gynecol; 2019 Apr; 53(4):443-453. PubMed ID: 30697855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early preterm preeclampsia outcomes by intended mode of delivery.
    Coviello EM; Iqbal SN; Grantz KL; Huang CC; Landy HJ; Reddy UM
    Am J Obstet Gynecol; 2019 Jan; 220(1):100.e1-100.e9. PubMed ID: 30273585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of labour at 41 weeks or expectant management until 42 weeks: A systematic review and an individual participant data meta-analysis of randomised trials.
    Alkmark M; Keulen JKJ; Kortekaas JC; Bergh C; van Dillen J; Duijnhoven RG; Hagberg H; Mol BW; Molin M; van der Post JAM; Saltvedt S; Wikström AK; Wennerholm UB; de Miranda E
    PLoS Med; 2020 Dec; 17(12):e1003436. PubMed ID: 33290410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study.
    Gurol-Urganci I; Jardine JE; Carroll F; Draycott T; Dunn G; Fremeaux A; Harris T; Hawdon J; Morris E; Muller P; Waite L; Webster K; van der Meulen J; Khalil A
    Am J Obstet Gynecol; 2021 Nov; 225(5):522.e1-522.e11. PubMed ID: 34023315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes.
    Stock SJ; Bricker L; Norman JE; West HM
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008968. PubMed ID: 27404120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal and neonatal outcomes of elective induction of labor.
    Caughey AB; Sundaram V; Kaimal AJ; Cheng YW; Gienger A; Little SE; Lee JF; Wong L; Shaffer BL; Tran SH; Padula A; McDonald KM; Long EF; Owens DK; Bravata DM
    Evid Rep Technol Assess (Full Rep); 2009 Mar; (176):1-257. PubMed ID: 19408970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental growth factor testing in the management of late preterm preeclampsia without severe features: a multicenter, randomized, controlled trial.
    Peguero A; Herraiz I; Perales A; Melchor JC; Melchor I; Marcos B; Villalain C; Martinez-Portilla R; Mazarico E; Meler E; Hernandez S; Matas I; Del Rio M; Galindo A; Figueras F
    Am J Obstet Gynecol; 2021 Sep; 225(3):308.e1-308.e14. PubMed ID: 33823150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying the additional maternal morbidity in women with preeclampsia with severe features in whom immediate delivery is recommended.
    Jaber S; Jauk VC; Cozzi GD; Sanjanwala AR; Becker DA; Harper LM; Casey BM; Sinkey RG; Subramaniam A
    Am J Obstet Gynecol MFM; 2022 May; 4(3):100565. PubMed ID: 35033750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of fetal growth restriction on pregnancy outcome in women undergoing expectant management for preterm pre-eclampsia.
    Cluver CA; Bergman L; Bergkvist J; Imberg H; Geerts L; Hall DR; Mol BW; Tong S; Walker SP
    Ultrasound Obstet Gynecol; 2023 Nov; 62(5):660-667. PubMed ID: 37289938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elective induction of labor at 39 weeks compared with expectant management: a meta-analysis of cohort studies.
    Grobman WA; Caughey AB
    Am J Obstet Gynecol; 2019 Oct; 221(4):304-310. PubMed ID: 30817905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early delivery or expectant management for late preterm preeclampsia: A meta-analysis of randomized controlled trials.
    Chatzakis C; Liberis A; Zavlanos A; Petousis S; Tsakmaki E; Dinas K; Sotiriadis A
    Acta Obstet Gynecol Scand; 2021 Aug; 100(8):1392-1400. PubMed ID: 33742472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Full-term induction of labor vs expectant management and cesarean delivery in women with obesity: systematic review and meta-analysis.
    Krogh LQ; Glavind J; Henriksen TB; Thornton J; Fuglsang J; Boie S
    Am J Obstet Gynecol MFM; 2023 May; 5(5):100909. PubMed ID: 36842468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of preeclampsia.
    Dekker GA
    Pregnancy Hypertens; 2014 Jul; 4(3):246-7. PubMed ID: 26104648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.